Northern Trust
PMD

Northern Trust’s Psychemedics Corporation PMD Stock Holding History

Northern Trust’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,910
Closed -$43.7K – 4506
2024
Q3 		$43.7K Buy
18,910
+3,674
+24% +$8.26K ﹤0.01% 4237
2024
Q2 		$36.9K Sell
15,236
-74
-0.5% -$188 ﹤0.01% 4256
2024
Q1 		$44.9K Hold
15,310
– – ﹤0.01% 4241
2023
Q4 		$45.3K Sell
15,310
-1,554
-9% -$4.14K ﹤0.01% 4254
2023
Q3 		$67K Sell
16,864
-1,753
-9% -$7.82K ﹤0.01% 4100
2023
Q2 		$84.9K Buy
18,617
+490
+3% +$2.48K ﹤0.01% 4080
2023
Q1 		$95.2K Buy
18,127
+1,097
+6% +$6.08K ﹤0.01% 4092
2022
Q4 		$83.5K Sell
17,030
-206
-1% -$1.22K ﹤0.01% 4151
2022
Q3 		$111K Sell
17,236
-110
-0.6% -$707 ﹤0.01% 4082
2022
Q2 		$110K Sell
17,346
-1,410
-8% -$9.03K ﹤0.01% 4139
2022
Q1 		$129K Sell
18,756
-369
-2% -$2.61K ﹤0.01% 4274
2021
Q4 		$134K Sell
19,125
-563
-3% -$4.5K ﹤0.01% 4332
2021
Q3 		$165K Buy
19,688
+41
+0.2% +$300 ﹤0.01% 4257
2021
Q2 		$137K Buy
19,647
+31
+0.2% +$217 ﹤0.01% 4281
2021
Q1 		$122K Sell
19,616
-4,141
-17% -$27.4K ﹤0.01% 4241
2020
Q4 		$121K Sell
23,757
-3,657
-13% -$15.9K ﹤0.01% 4081
2020
Q3 		$121K Buy
27,414
+88
+0.3% +$429 ﹤0.01% 3925
2020
Q2 		$151K Buy
27,326
+140
+0.5% +$782 ﹤0.01% 3827
2020
Q1 		$164K Buy
27,186
+418
+2% +$3.52K ﹤0.01% 3722
2019
Q4 		$245K Sell
26,768
-536
-2% -$4.95K ﹤0.01% 3734
2019
Q3 		$248K Sell
27,304
-1,518
-5% -$12.9K ﹤0.01% 3703
2019
Q2 		$290K Sell
28,822
-7,551
-21% -$85.7K ﹤0.01% 3707
2019
Q1 		$510K Sell
36,373
-7,241
-17% -$124K ﹤0.01% 3533
2018
Q4 		$692K Sell
43,614
-1,215
-3% -$20.9K ﹤0.01% 3469
2018
Q3 		$843K Buy
44,829
+5,783
+15% +$115K ﹤0.01% 3513
2018
Q2 		$751K Sell
39,046
-200
-0.5% -$4.05K ﹤0.01% 3512
2018
Q1 		$838K Sell
39,246
-375
-0.9% -$7.79K ﹤0.01% 3433
2017
Q4 		$815K Buy
39,621
+2,694
+7% +$50K ﹤0.01% 3453
2017
Q3 		$681K Sell
36,927
-1,300
-3% -$28.6K ﹤0.01% 3522
2017
Q2 		$953K Buy
38,227
+18,778
+97% +$395K ﹤0.01% 3456
2017
Q1 		$389K Buy
19,449
+2,365
+14% +$51.9K ﹤0.01% 3604
2016
Q4 		$421K Buy
17,084
+345
+2% +$7.73K ﹤0.01% 3573
2016
Q3 		$331K Buy
16,739
+1,324
+9% +$24.6K ﹤0.01% 3601
2016
Q2 		$212K Hold
15,415
– – ﹤0.01% 3710
2016
Q1 		$212K Buy
15,415
+1,206
+8% +$13.8K ﹤0.01% 3710
2015
Q4 		$144K Buy
14,209
+700
+5% +$7.63K ﹤0.01% 3856
2015
Q3 		$135K Buy
13,509
+847
+7% +$9.87K ﹤0.01% 3855
2015
Q2 		$188K Sell
12,662
-2,232
-15% -$34.8K ﹤0.01% 3796
2015
Q1 		$247K Sell
14,894
-1,172
-7% -$18.3K ﹤0.01% 3800
2014
Q4 		$244K Sell
16,066
-54
-0.3% -$784 ﹤0.01% 3759
2014
Q3 		$228K Sell
16,120
-393
-2% -$5.58K ﹤0.01% 3793
2014
Q2 		$234K Sell
16,513
-35
-0.2% -$532 ﹤0.01% 3813
2014
Q1 		$284K Buy
16,548
+4,010
+32% +$66.5K ﹤0.01% 3696
2013
Q4 		$184K Sell
12,538
-100
-0.8% -$1.38K ﹤0.01% 3742
2013
Q3 		$167K Sell
12,638
-1,338
-10% -$16.6K ﹤0.01% 3703
2013
Q2 		$150K Buy
+13,976
New +$157K ﹤0.01% 3724

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Northern Trust's PMD Position: Q4 2024 in Review

Northern Trust sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 18,910 shares — an estimated $43.7K sold.

Northern Trust first reported a position in PMD in Q2 2013 and held it in 46 quarters. The position peaked at $953K in Q2 2017. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Northern Trust reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Northern Trust sold 18,910 Psychemedics Corporation shares in Q4 2024, an estimated $43.7K.
  • Northern Trust first reported a position in Psychemedics Corporation in Q2 2013 and held it in 46 quarters.
  • Northern Trust's Psychemedics Corporation position peaked at $953K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.